TRiNDS is a new contract research organization born from the Cooperative International Neuromuscular Research Group (CINRG) academic consortium. Therapeutic Research in Neuromuscular Disorders Solutions (TRiNDS) provides specialized clinical trial support and post marketing solutions for neuromuscular, particularly Duchenne, clinical research.
Research focus: Clinical trial support
Status: TRiNDS is involved in all phases of the clinical trial process and can help guide the development of neuromuscular clinical research studies.
“We are proud to fill an emerging need in drug development for rare and orphan diseases like Duchenne. We are honored to collaborate with CureDuchenne Ventures who continues to be an innovator in funding Duchenne research and provides a strong link to the Duchenne community.” — Lauren Morgenroth, Chief Operating Officer of TRiNDS.